Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
Eurosurveillance, Volume 16, Issue 31, 04 August 2011
Surveillance and outbreak reports
Secondary transmissions during the outbreak of Shiga toxin-producing Escherichia coli O104 in Hesse, Germany, 2011
A M Hauri (
)<SUP>1</SUP>, U G?tsch<SUP>2</SUP>, I Strotmann<SUP>3</SUP>, J Krahn<SUP>4</SUP>, G Bettge-Weller<SUP>1</SUP>, H J Westbrock<SUP>1</SUP>, O Bellinger<SUP>2</SUP>, H Upphoff<SUP>1</SUP>
Citation style for this article: Hauri AM, G?tsch U, Strotmann I, Krahn J, Bettge-Weller G, Westbrock HJ, Bellinger O, Upphoff H. Secondary transmissions during the outbreak of Shiga toxin-producing Escherichia coli O104 in Hesse, Germany, 2011. Euro Surveill. 2011;16(31)
ii=19937. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19937
Date of submission: 25 July 2011 <HR>During the recent outbreak of Shiga toxin-producing Escherichia coli (STEC) O104:H4 in Germany most cases notified in the State of Hesse (6 million inhabitants) were linked to satellite clusters or had travelled to the outbreak area in northern Germany. Intensified surveillance was introduced to rapidly identify cases not linked to known clusters or cases and thus to obtain timely information on possible further contaminated vehicles distributed in Hesse, as well to describe the risk of secondary transmission among known cases. As of 21 July 2011, 56 cases of haemolytic uraemic syndrome (HUS) including two fatal cases, and 124 cases of STEC gastroenteritis meeting the national case definitions have been reported in Hesse. Among the 55 HUS and 81 STEC gastroenteritis cases that met the definition for the ongoing outbreak, one HUS case and eight STEC gastroenteritis cases may have acquired their infection through secondary transmission. They include six possible transmissions within the family, two possible nosocomial and one possible laboratory transmission. Our results do not suggest an increased transmissibility of the outbreak strain compared to what is already known about E. coli O157 and other STEC serotypes.
- --------
Eurosurveillance, Volume 16, Issue 31, 04 August 2011
Surveillance and outbreak reports
Secondary transmissions during the outbreak of Shiga toxin-producing Escherichia coli O104 in Hesse, Germany, 2011
A M Hauri (
- Hesse State Health Office, Dillenburg, Germany
- Public Health Authority, Frankfurt, Germany
- Public Health Authority, Kassel, Germany
- Public Health Authority, Darmstadt-Dieburg, Germany
Citation style for this article: Hauri AM, G?tsch U, Strotmann I, Krahn J, Bettge-Weller G, Westbrock HJ, Bellinger O, Upphoff H. Secondary transmissions during the outbreak of Shiga toxin-producing Escherichia coli O104 in Hesse, Germany, 2011. Euro Surveill. 2011;16(31)
ii=19937. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19937 Date of submission: 25 July 2011 <HR>During the recent outbreak of Shiga toxin-producing Escherichia coli (STEC) O104:H4 in Germany most cases notified in the State of Hesse (6 million inhabitants) were linked to satellite clusters or had travelled to the outbreak area in northern Germany. Intensified surveillance was introduced to rapidly identify cases not linked to known clusters or cases and thus to obtain timely information on possible further contaminated vehicles distributed in Hesse, as well to describe the risk of secondary transmission among known cases. As of 21 July 2011, 56 cases of haemolytic uraemic syndrome (HUS) including two fatal cases, and 124 cases of STEC gastroenteritis meeting the national case definitions have been reported in Hesse. Among the 55 HUS and 81 STEC gastroenteritis cases that met the definition for the ongoing outbreak, one HUS case and eight STEC gastroenteritis cases may have acquired their infection through secondary transmission. They include six possible transmissions within the family, two possible nosocomial and one possible laboratory transmission. Our results do not suggest an increased transmissibility of the outbreak strain compared to what is already known about E. coli O157 and other STEC serotypes.